B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Nigericin

300 PubMed studies analyzed · Evidence Score: 42

Research Domains

Nigericin has been studied across 17 research domains including 🧠 Focus & Attention, ⚡ Energy & Fatigue, 🔬 Oncology, 🔬 Inflammation, 🦴 Bone & Joint. The primary research focus is 🧠 Focus & Attention with 28% of studies addressing this area.

Loading evidence profile...

This evidence profile for Nigericin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.